First‐to‐Patent Does not Predict First‐ or Best‐in‐Class: Analysis of Approved Small Molecule vs. Biologic Drugs

Publisher： John Wiley & Sons Inc

E-ISSN： 1532-6535|97|1|19-21

ISSN： 0009-9236

Source： CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.97, Iss.1, 2015-01, pp. : 19-21

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phenotypic vs. Target‐Based Drug Discovery for First‐in‐Class Medicines

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 93, Iss. 4, 2013-04 ,pp. : 299-301

John Wiley & Sons Inc

Access to resources Recommend Favorite

Factors associated with the choice of the first biologic in psoriasis: real‐life analysis from the Psobioteq cohort

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 31, Iss. 12, 2017-12 ,pp. : 2046-2054

John Wiley & Sons Inc

Access to resources Recommend Favorite

Does Change in Gait while Counting Backward Predict the Occurrence of a First Fall in Older Adults?

By  

Gerontology, Vol. 54, Iss. 4, 2008-04 ,pp. : 217-223

Karger

Access to resources Recommend Favorite

The number of FoxP3+ cells in transbronchial lung allograft biopsies does not predict bronchiolitis obliterans syndrome within the first five years after transplantation

By  

CLINICAL TRANSPLANTATION (ELECTRONIC), Vol. 29, Iss. 3, 2015-03 ,pp. : 179-184

John Wiley & Sons Inc

Access to resources Recommend Favorite

First‐ and second‐trimester tests to predict stillbirth in unselected pregnant women: a systematic review and meta‐analysis

By  

BJOG : AN INTERNATIONAL JOURNAL OF OBSTETRICS & GYNAECOLOGY, Vol. 122, Iss. 1, 2015-01 ,pp. : 41-55

John Wiley & Sons Inc

Access to resources Recommend Favorite